According to World Health Organization (WHO) estimates, 21.6 million new cases will be recorded each year by 2030. Genetic influences, individual health behaviors, and environmental factors also contribute to this effect, in addition to demographic development.
Network of Specialists
Companies invest large sums of money each year in drug research, production, and distribution. Developing new active ingredients requires specialized knowledge and experts, which is why this process is always carried out in a global network. The commercial manufacture of pharmaceutical active ingredients is an important part of this network.
Many active ingredients for treating tumors are highly toxic and thus have special handling requirements, requiring manufacturers to take appropriate protective measures. High containment facilities offer the best technological standards for the environment and employees. The level of impurity is another critical factor. The higher the grade of composition, the less likely that problems will arise further down the processing chain.